The specific activity of 170-hydroxysteroid dehydrogenase was measured in normal human myometrium, and in leiomyoma specimens obtained from the same tumor-bearing uterus. In all cases the normal tissue showed greater conversion of estradiol-17/3 into estrone than the neoplastic tissues. In normal myometrium of fertile women, the specific enzyme activity depended on the phase of the menstrual cycle, the highest values of 170-hydroxysteroid dehydrogenase activity being found in the early secretory phase.
Introduction
It is known that ovarian hormones play an important role in regulating the growth patterns of human myometrium. It is generally agreed that the early steps in steroid hormone action involve the binding of the receptor protein is strongly affected by several possible estradiol metabolites. In this paper we report studies on the conversion of estradiol· 17/3 to estrone catalyzed by the 17/J-hydroxysteroid dehydrogenase (EC 1.1.1.51) in various intracellular fractions of normal myometria and leiomyoma. The fact that the growth of leiomyomas is influenced by hormonal variations during the menstrual cycle and pregnancy indicates that leiomyoma cells are also under steroidal control.
Materials and Methods
Steroids [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C)Estradiol-170 (spec, activity 1961 GBq/mol = 53 mCi/mmol) was purchased from The Radiochemical Centre, Amersham, England, and purified by thin-layer chromatography. Unlabelled steroids were a gift of Schering AG (Berlin, Germ any).
Miscellaneous DNA (thymus), RNA (yeast), NAD, NADP, ADP, hexokinase, succinate, 2-oxoglutarate, cytochrome c (bovine) and glucose-6-phosphate dehydrogenase were obtained from Boehringer (Mannheim, Germany); Triton X-100 was a product of Serva (Heidelberg, Germany); Ficoll was purchased from Pharmacia Fine Chemicals (Uppsala, Sweden); Lubrol WX from I. C. I. Organics Inc. (Frankfurt, Germany). All other chemicals and organic solvents were of reagent grade and came from E. Merck (Darmstadt, Germany). Tissue preparation All tissues, obtained by hysterectomy, were subjected to histological examination. All premenopausal uterine tissue samples were correlated with the stage of the menstrual cycle, using histological examination of the endometrium according to the method ofNoyes et aL (5) . Representative portions (5 g) of minced fresh human myometrium and leiomyomata were washed in ice-cold NaCl (9 g/1), weighed and homogenized with an Ultra Turrax homogenizer followed by homogenization with a glass homogenizer fitted with a teflon pestle in 10 volumes of buffer A (50 ml per 5 g tissue). The homogenate was filtered through 4 layers of cheese cloth and centrifuged for 15 min at 850 £. The resulting nuclear sediment was layered on a cushion of buffer B and resedimented at 60,000 # for 60 min. The sediment was washed twice in buffer A, suspended in buffer C to which 5 ml/1 of Triton X-100 had been added, layered on buffer C containing 2.2 mol/1 sucrose (without detergent) and centrifuged at 60,000 g for 60 min. The resulting precipitate was designated "purified nuclei". Mitochondria!, peroxysome-and lysome-enriched fractions were obtained from the 850 £ supernatant by centrifugation at 12,000 g for 15 min. The precipitate was washed once in buffer A and purified according to the method of Brown (6) . Preparation of sub mitochondria! fractions was performed by subjecting the washed mitochondrial pellets to controlled osmotic lysis and ultrasonic vibration, followed by differential centrifugation as described in detail by Follow et al. (7) . Microsomes were sedimented from the 12,000 g supernatant at 105,000 g for 60 min, washed twice in buffer A, and separated into rough and smooth particles according to the method ofDallner et al. (8) . The resulting supernatant fluid was designated "cy tosol". The purity of each fraction was checked by marker enzymes, DNA/RNA ratio, and electron microscopy.
Buffers

170-Hydroxysteroid dehydrogenase
Standard reaction mixtures (total volume 4 ml) contained 0.1 mol/1 Tris/HCl, pH 7.4, 200 ml/1 glycerol, 0.1 MCi = 3.7 kBq of [ 14 C]estradiol plus 10 μηιοΐ/ΐ unlabelled steroid added in 100 μΐ of propylene glycol, enzyme preparations and NAD (400 μηιοΐ/l). Reactions were started by addition of coenzyme and terminated by addition of 5 ml of ether/chloroform (4 ml + 1 ml). The extracts of the reaction mixtures (3 X 5 ml ether/chloroform) were pooled, evaporated under nitrogen and chromatographed on silica gel thin-layer plates (E. Merck, Darmstadt, Germany). Reference steroids were located by fluorescence absorption. Radioactivity of separated steroids was quantitated by a radio-chromatogram scanner (LB 2723, Berthold, Wildbad, Germany) equipped with a 2ττ counting device and count integrator. An aliquot of the pooled extracts was removed for liquid scintillation counting. The products of the reactions were identified as described earlier (9) (table 1).
Chemical analysis Protein was measured using the method ofLowry (10) with bovine serum albumin as standard. DNA was measured by the Burton diphenylamine method (11) using calf thymus DNA as standard, and RNA was determined according to Ceriotti (12) with yeast RNA as standard.
Results
The degree of separation of the subcellular fractions was determined by the analysis of each fraction for characteristic marker enzymes ( tion of the enzyme activities indicated that every subcellular fraction was nearly completely separated from the other fractions. It should be noted that the purified mitochondrial fraction still had a trace of microsomal components and could not be separated completely from lysosomes and peroxysomes. The RNA/DNA ratio is in agreement with reported values for pure nuclei (table 3) . Most of the 17/J-hydroxysteroid dehydrogenase activity is located in the mitochondrial and microsomal fractions, as shown in figure 1. Cytosol and purified nuclei contained 5 to 6 times less activity per mg protein.
From table 4 it can be seen that the specific activity of 17|3-hydroxysteroid dehydrogenase in rough and smooth microsomal particles was similar to that in crude doublewashed microsomes. This indicates that the miprosomal 17j3-hydroxysteroid dehydrogenase is bound tightly to the membranes of the endoplasmic reticulum.
Prolonged centrifugation of the cytoplasmic fraction (diluted 1 + 3 with buffer) resulted in sedimentation of 35% of the cytoplasmic activity of 17/ttiydroxysteroid dehydrogenase. No major change in specific activity of the supernatant was observed, and NADPH:cytochromec-reductase as a marker enzyme of the microsomal fraction could not be detected in the pellet (table 5) .
The activity of NADPH:cytochrome-c-reductase (marker enzyme of microsomes) in the mitochondrial fraction could be reduced considerably by several washings, while in the microsomal fraction the activity stayed nearly the same under the same conditions. The final microsomal contamination of the mitochondria was 2.4% (table 6) .
The 17/J-hydroxysteroid dehydrogenase of mitochondria was found to be associated with both the outer and inner membranes of the organelle ( a three-fold increase in specific activity was achieved as compared to washed mitochondria. The intermembrane fraction and the matrix did not convert estradiol into estrone. Figure 1 shows that the specific activity of 17/3-hydroxy steroid dehydrogenase in nonmalignant human myometrium of premenopausal women depends on the phase of the menstrual cycle. Specific activity of 17/Hiydroxysteroid dehydrogenase was approximately 5 to 6-fold higher during the early secretory than during the proliferative phase. From table 8 it becomes evident that the specific activity of 17|3-hydroxysteroid dehydrogenase in subcellular fractions of leiornyoma is very low compared with normal myometrium from the uterus bearing the tumor. Figure 2 shows typical thin-layer radiochromatograms of estradiol metabolism in microsomal, mitochondrial, cytoplasmic and nuclear fraction of normal myometrium and leiomyoma obtained from the same uterus.
Kinetic analyses
Most of the estradiol was converted to estrone; no effort was made to identify trace amounts of other metabolites. For further characterization, some kinetic measurements of 17ß-hydroxysteroid dehydrogenase were performed.
The transformation of estradiol into estrone as a function of enzyme concentration is illustrated in figure 3 . There is a linear relationship between the amount of estrone formed arid the concentration of enzyme in various subcellular fractions.
In order to establish the optimal incubation time for subsequent studies, a rate study of estradiol oxidation was performed by measuring the formation of estrone from [ 14 C]estradiol incubated with various subcellular fractions. As shown in figure 4 , the rate of estradiol oxidation is relatively constant at 37 °C up to 120 min, Estradiol oxidation exhibited maximal activity over a pH-range of 7.5 to 9.5 in both tissue types. Enzymatic activity decreased to less than 10% of the maximum at the extreme of pH values of 5.0 and 10.5. The pH-optimum for the hydrogenation of estrone was 6.0 ( fig. 5 ). The effect of varying the incubation temperature on 170-hydroxysteroid dehydrogenase activity is shown in figure 6 . 17/J-hydrqxysteroid dehydrogenase activity was greatest at 38 °C. No difference could be observed between normal and neoplastic myometrium. K m -values and maximal velocities (substrate estradiol) of soluble, microsomal, mitochondrial and nuclear 17/J-hydroxysteroid dehydrogenase from proliferative, secretory and neoplastic myometrium (with NAD and NADP as cofactor) are presented in table 9. Kinetic parameters from proliferative and neoplastic myometrium were very similar. K m -values from secretory endometrium were lower and maximal velocities higher than in proliferative tissue and leiomyoma. In all tissues estradiol was oxidized more rapidly with NAD than with NADP. The effect of NAD and NADP concentrations on the rate of estradiol oxidation (estradiol was kept constant at 10 μιηοΐ/ΐ) was estimated using microsomal enzyme preparation of normal secretory human myometrium. Duplicate determinations gave similar K m -values of 0.638 mmol/1 for NAD and,0.53 mmol/1 for NADP. The V for NAD and NADP were 68 pmol/min · mg protein and 26 pmol/min · mg protein, respectively. Various subcellular fractions of normal human myometrium, from known stages of the menstrual cycle, and of leiomyoma were incubated separately with estradiol-17/3, estrone, testosterone and androstenedione.
The yield of the main products from these substrates is given in table 10. Trace amounts of other products (less than 2% of total products) were not identified. Testosterone was oxidized less rapidly in all tissues than estradiol-17j3. Androstenedione was reduced at about 1/3 of the rate of estrone. The relative specific activities for normal and neoplastic tissue were always similar. of coenzymes. These may change the state of equilibrium between estradiol and estrone to some extent, though from studies on the human placental 17/J-hydroxysteroid dehydrogenase (24, 25) it has been shown that under physiological conditions the equilibrium of the reaction lies on the side of estrone. Furthermore it has been shown by supervision experiments with human endometrium (20) (21) (22) , that estrone (in contrast to estradiol) is not accumulated in the target cell. This observation seems all the more important since estrone is known to compete for specific estradiol receptor and enzyme binding-sites.
We can only speculate about the physiological relevance of this phenomenon. The increase in the 170-hydroxysteroid dehydrogenase activity in the cells of the target organ results in an increase in the amount of estradiol converted to estrone. Since the myometrium cell is controlled at least in part by the estradiol receptor mechanism, the progesterone-induced increase in 17/3-hydroxysteroid dehydrogenase activity in the second half of the cycle causes a distinct reduction in the estradiol sensitivity of the cell. This "protection effect" of the 1704iydroxysteroid dehydrogenase activity against a flooding of the target cell with estradiol is enhanced by the negative effector action of progesterone on the estradiol receptor observed in many animals. Together the two phenomena are responsible for the antiestrogenic effect of progesterone in the second half of the cycle.
Since the activity of 17/J-hydroxysteroid dehydrogenase in leiomyomas is low in comparison to normal tissue from the same uterus, it seems likely that the "protection effect" against biologically active estradiols is altered in leiomyomas. Whether this alteration might be one of the causes for estradiol-influenced origin of leiomyomas during the fertility period of the woman cannot be definitively decided at the present time.
